Biphenotypic sinonasal sarcoma
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
| Biphenotypic sinonasal sarcoma | |
|---|---|
| Diagnosis in short | |
 Micrograph showing a biphenotypic sinonasal sarcoma. H&E stain. (WC/LESTERTHEINVESTOR) | |
|
| |
| Synonyms | low-grade sinonasal sarcoma with neural and myogenic features |
|
| |
| LM | bland hypercellular stroma typically without many mitoses, invaginating glandular epithelium |
| LM DDx | solitary fibrous tumour, schwannoma, sinonasal-type hemangiopericytoma, benign nasal polyp |
| IHC | S-100 +ve, actin +ve, beta-catenin +ve (nuclear) |
| Molecular | PAX3-MAML3 fusion - t(2;4)(q35;q31.1) |
| Site | head and neck - ethmoid sinus and/or nasal cavity |
|
| |
| Clinical history | female predominant (3:1) |
| Prevalence | very rare ~ large series 28 individuals as of 2012 |
Biphenotypic sinonasal sarcoma, abbreviated SNS,[1] is a rare bland appearing malignant tumour of the head and neck.
It is also known as low-grade sinonasal sarcoma with neural and myogenic features.[2]
General
- Rare - largest series published (as of 2012) 28 patients.[3]
- Female predominant - (female:male = 3:1[3]).
Prognosis:
- No (far away) metastasis or death in a series of 28 patients.[3]
Gross
- Usually ethmoid sinus and/or nasal cavity.[3]
Microscopic
Features:
- Bland hypercellular stroma typically without many mitoses.
- Invaginating glandular epithelium.
Note:
- May have rhabdomyoblastic differentiation - case report.[4]
DDx:
Images
BSS. (WC/LESTERTHEINVESTOR)
BSS. (WC/LESTERTHEINVESTOR)
IHC
Features:
- S-100 +ve - strong (28 +ve of 28 cases[3]).
- Actin +ve (27 +ve of 28 cases[3]).
- Beta-catenin - nuclear +ve.[5][2]
Others:[2]
- Desmin -ve.
- AE1/AE3 -ve.
- Vimentin +ve.
Images
BSS S-100. (WC/LESTERTHEINVESTOR)
BSS - SMA. (WC/LESTERTHEINVESTOR)
Molecular
- PAX3-MAML3 fusion - t(2;4)(q35;q31.1).[1]
See also
References
- ↑ 1.0 1.1 Wang, X.; Bledsoe, KL.; Graham, RP.; Asmann, YW.; Viswanatha, DS.; Lewis, JE.; Lewis, JT.; Chou, MM. et al. (Jul 2014). "Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma.". Nat Genet 46 (7): 666-8. doi:10.1038/ng.2989. PMID 24859338.
- ↑ 2.0 2.1 2.2 Powers, KA.; Han, LM.; Chiu, AG.; Aly, FZ. (May 2015). "Low-grade sinonasal sarcoma with neural and myogenic features--diagnostic challenge and pathogenic insight.". Oral Surg Oral Med Oral Pathol Oral Radiol 119 (5): e265-9. doi:10.1016/j.oooo.2014.10.007. PMID 25488011.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Lewis, JT.; Oliveira, AM.; Nascimento, AG.; Schembri-Wismayer, D.; Moore, EA.; Olsen, KD.; Garcia, JG.; Lonzo, ML. et al. (Apr 2012). "Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases.". Am J Surg Pathol 36 (4): 517-25. doi:10.1097/PAS.0b013e3182426886. PMID 22301502.
- ↑ Huang, SC.; Ghossein, RA.; Bishop, JA.; Zhang, L.; Chen, TC.; Huang, HY.; Antonescu, CR. (Jan 2016). "Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.". Am J Surg Pathol 40 (1): 51-9. doi:10.1097/PAS.0000000000000492. PMID 26371783.
- ↑ http://dx.doi.org/10.1016/j.humpath.2016.04.009